Atypical spindle cell/pleomorphic lipomatous tumor with a sarcomatous component showing high mitotic activity and Ki-67 labeling index: report of a unique case mimicking dedifferentiated liposarcoma

• Published in: Medical molecular morphology 2022-12, Vol.55 (4), p.323-328
• Main Authors: Sugita, Shintaro, Sugawara, Taro, Emori, Makoto, Aoyama, Tomoyuki, Hosaka, Michiko, Segawa, Keiko, Fujita, Hiromi, Hasegawa, Tadashi
• Format: Article
• Language: English
• Subjects: Anatomy; Cancer; Case Report; Cell differentiation; Cell proliferation; Cyclin-dependent kinase 4; Cyclin-dependent kinases; Fluorescence in situ hybridization; Giant cells; Liposarcoma; MDM2 protein; Medicine; Medicine & Public Health; Metastases; Mimicry; Mitosis; Molecular Medicine; Pathology; Retina; Retinoblastoma; Retinoblastoma protein; Tumor cells
• ISSN: 1860-1480; 1860-1499
• DOI: 10.1007/s00795-022-00327-8

Atypical spindle cell/pleomorphic lipomatous tumor (ASPLT) is a new entity of benign adipocytic tumor that spans a wide spectrum of histology from adipocytic to spindle cell/pleomorphic tumors. The latter non-adipocytic component rarely shows sarcomatous features although ASPLTs are not thought to dedifferentiate. A 78-year-old woman with ASPLT in the left thigh had a sarcomatous component with high mitotic activity and Ki-67 labeling index (LI) mimicking dedifferentiated liposarcoma. The adipocytic component consisted of various-sized adipocytic cells with few lipoblasts. The sarcomatous component consisted of a fascicular proliferation of atypical spindle cells with scattered large bizarre and multinucleated giant cells. Mitotic figures including atypical mitoses were frequently observed. Immunohistochemically, the tumor cells were positive for cluster of differentiation 34 but not mouse double minute 2 homolog (MDM2), cyclin-dependent kinase 4 (CDK4), or retinoblastoma (Rb) protein. Ki-67 LI in the sarcomatous component reached 40%. MDM2 and CDK4 genes were not amplified and 13q14 including the RB1 locus was deleted according to fluorescence in situ hybridization. The patient is alive with no evidence of local recurrence or distant metastasis 3.5 years after surgery. As ASPLT may exhibit morphological variation, it is important to rule out dedifferentiated liposarcoma with careful pathological examination.